NovAccess Global Inc. (XSNX)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 28, 2025, 11:02 AM EDT
NovAccess Global Employees
NovAccess Global had 3 employees as of September 30, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$631,000
Market Cap
18.57K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
NovAccess Global News
- 1 year ago - NovAccess Global Advisory on Annual Meeting of Shareholders - Accesswire
- 1 year ago - NovAccess Global Announces New License to Advance its Immunotherapy Platform - Accesswire
- 1 year ago - NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders - Accesswire
- 1 year ago - NovAccess Global Announces $10.7 Million Financing - Accesswire
- 1 year ago - NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit - Newsfile Corp
- 1 year ago - NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board - Accesswire
- 1 year ago - NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform - Accesswire
- 1 year ago - NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day - Accesswire